ReplyLetter to the Editor
Radiation Dosimetry of 131I-19-Iodocholesterol: The Pitfalls of Using Tissue Concentration Data—Reply
Alan S. Kirschner, Rodney D. Ice and W. H. Beierwaltes
Journal of Nuclear Medicine March 1975, 16 (3) 248-249;
Alan S. Kirschner
Rodney D. Ice
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Radiation Dosimetry of 131I-19-Iodocholesterol: The Pitfalls of Using Tissue Concentration Data—Reply
Alan S. Kirschner, Rodney D. Ice, W. H. Beierwaltes
Journal of Nuclear Medicine Mar 1975, 16 (3) 248-249;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Preclinical Characterization of DPI-4452: A 68Ga/177Lu Theranostic Ligand for Carbonic Anhydrase IX
- RADAR Guide: Standard Methods for Calculating Radiation Doses for Radiopharmaceuticals, Part 1--Collection of Data for Radiopharmaceutical Dosimetry
- Comparative Preclinical Biodistribution, Dosimetry, and Endoradiotherapy in Metastatic Castration-Resistant Prostate Cancer Using 19F/177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T
- Combined VLA-4-Targeted Radionuclide Therapy and Immunotherapy in a Mouse Model of Melanoma
- Initial Evaluation of an Adenosine A2A Receptor Ligand, 11C-Preladenant, in Healthy Human Subjects
- Initial Human PET Studies of Metabotropic Glutamate Receptor Type 1 Ligand 11C-ITMM
- MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of {alpha}-Particle Emitters for Targeted Radionuclide Therapy
- Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography